NSE - Delayed Quote INR
Caplin Point Laboratories Limited (CAPLIPOINT.NS)
1,806.70
-77.70
(-4.12%)
At close: April 25 at 3:30:01 PM GMT+5:30
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 3 |
| Avg. Estimate | 0 | 0 | 71.75 | 79.7 |
| Low Estimate | 0 | 0 | 70.9 | 71.4 |
| High Estimate | 0 | 0 | 72.6 | 84.4 |
| Year Ago EPS | -- | -- | 59.9 | 71.75 |
Revenue Estimate
| Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 2 | 3 |
| Avg. Estimate | 5.12B | -- | 19.58B | 22.33B |
| Low Estimate | 5.12B | -- | 19.57B | 21.93B |
| High Estimate | 5.12B | -- | 19.6B | 22.6B |
| Year Ago Sales | 4.53B | -- | 16.94B | 19.58B |
| Sales Growth (year/est) | 12.99% | -- | 15.60% | 14.02% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 71.75 | 79.7 |
| 7 Days Ago | 0 | 0 | 71.75 | 79.7 |
| 30 Days Ago | 0 | 0 | 70.9 | 77.35 |
| 60 Days Ago | 0 | 0 | 70.9 | 77.35 |
| 90 Days Ago | 0 | 0 | 67.75 | 76.4 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CAPLIPOINT.NS | -- | -- | 19.78% | 11.08% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
ABBOTINDIA.NS Abbott India Limited
29,705.00
-1.18%
MANKIND.NS Mankind Pharma Limited
2,557.50
-1.60%
SUVENPHAR.NS Suven Pharmaceuticals Limited
1,143.20
-5.11%
ERIS.NS Eris Lifesciences Limited
1,468.20
-2.90%
NATCOPHARM.BO NATCO Pharma Limited
889.65
-1.55%
IPCALAB.NS Ipca Laboratories Limited
1,419.00
-1.85%
FREDUN.BO Fredun Pharmaceuticals Limited
667.40
-3.23%
SUVENPHAR.BO Suven Pharmaceuticals Limited
1,143.25
-5.12%
CIPLA.NS Cipla Limited
1,525.90
-1.66%
LINCOLN.NS Lincoln Pharmaceuticals Limited
593.20
-1.09%